News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Myeloma Paper of the Day, April 20th, suggested by Robert Orlowski
Apr 20, 2025, 10:56

Myeloma Paper of the Day, April 20th, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Study of risk of lymphoid malignancy associated with cancer predisposition genes finds ATM, CHEK2, and TP53 mutations, among others, predispose to myeloma.”

“Risk of lymphoid malignancy associated with cancer predisposition genes”

Authors: Nicholas Boddicker, Raphael Mwangi, Dennis Robinson, Cristine Allmer, Allison Rosenthal, Thomas Witzig, Anne Novak, Susan Slager, Celine Vachon, James Cerhan et al.

Myeloma Paper of the Day, April 20th, suggested by Robert Orlowski

More posts featuring Robert Orlowski.

Allison Rosenthal Anne Novak cancer Celine Vachon Cristine Allmer Dennis Robinson James Cerhan Myeloma Myeloma Paper of the Day Nicholas Boddicker OncoDaily Oncology Raphael Mwangi Robert Orlowski Susan Slager Thomas Witzig
Special Coverage
Oncolibrary
Jun 1, 2025, 18:59
SERENA-6 Trial at ASCO 2025: Camizestrant Plus CDK4/6i Improves Outcomes in HR+/HER2– Advanced Breast Cancer with ctDNA-Detected ESR1 Mutations
Stories
Jun 1, 2025, 17:19
Shrenik Shah’s Story from Cancer Survivor to Global Advocate: From Silence to Stages
Insight
Jun 1, 2025, 17:02
Paolo Tarantino: The practice-changing results from ASCENT-04 presented by Sara Tolaney
Blog
Jun 1, 2025, 16:55
Oriol Mirallas: Early Data on SYNC-T Therapy for mCRPC Presented at ASCO 2025
Blog
Jun 1, 2025, 16:52
Armando Orlandi: Racial Disparities in HER2+ Breast Cancer Outcomes at ASCO 2025
Insight
Jun 1, 2025, 16:46
Shanda Blackmon: First trial of CAR-T cell cancer treatment for solid tumor response
Oncolibrary
Jun 1, 2025, 16:39
MATTERHORN Trial at ASCO 2025: Durvalumab plus FLOT Shows Significant Improvement of EFS in Resectable Gastric and GEJ Cancer Treatment
Opinion
Jun 1, 2025, 16:37
Massimo Di Maio: Overall Survival Analysis Should NOT be Adjusted for Subsequent Treatments
Blog
Jun 1, 2025, 16:37
Paolo Tarantino Shares DB06 Biomarker Analysis Insights from ASCO 2025
Insight
Jun 1, 2025, 16:36
Rebecca Shatsky: It’s high time for an oral taxane in breast cancer
Blog
Jun 1, 2025, 16:26
Runcie C.W. Chidebe: Project PINK BLUE is Exhibiting at the ASCO25 Annual Meeting
Blog
Jun 1, 2025, 16:26
Oyepeju Abioye-Akintola: Thank you to the ecancer team for the wonderful interview at ASCO 2025